All Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Negative Breast Cancer：a Multi-center, Multi-cohort Phase II Trial
Clinical trial NCT06636981 · RECRUITING
Trial details
- NCT number
- NCT06636981
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-04
- Primary completion
- 2029-09-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.